KR102657790B1 - Cosmetic composition for improving skin elasticity containing natural extracts - Google Patents
Cosmetic composition for improving skin elasticity containing natural extracts Download PDFInfo
- Publication number
- KR102657790B1 KR102657790B1 KR1020230164488A KR20230164488A KR102657790B1 KR 102657790 B1 KR102657790 B1 KR 102657790B1 KR 1020230164488 A KR1020230164488 A KR 1020230164488A KR 20230164488 A KR20230164488 A KR 20230164488A KR 102657790 B1 KR102657790 B1 KR 102657790B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- skin
- parts
- skin elasticity
- lactobacillus
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 63
- 230000037394 skin elasticity Effects 0.000 title claims abstract description 61
- 239000000203 mixture Substances 0.000 title claims abstract description 42
- 239000002537 cosmetic Substances 0.000 title claims abstract description 41
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000008213 purified water Substances 0.000 claims abstract description 18
- 241000226556 Leontopodium alpinum Species 0.000 claims abstract description 17
- 230000003750 conditioning effect Effects 0.000 claims abstract description 14
- 239000004909 Moisturizer Substances 0.000 claims abstract description 13
- 230000001333 moisturizer Effects 0.000 claims abstract description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 12
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 11
- 241000411851 herbal medicine Species 0.000 claims description 28
- 230000006872 improvement Effects 0.000 claims description 15
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 14
- 229940059958 centella asiatica extract Drugs 0.000 claims description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 235000014655 lactic acid Nutrition 0.000 claims description 7
- 239000004310 lactic acid Substances 0.000 claims description 7
- 239000012676 herbal extract Substances 0.000 claims description 6
- 241000566228 Anastatica hierochuntica Species 0.000 claims description 5
- 241000208340 Araliaceae Species 0.000 claims description 5
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 claims description 5
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 claims description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 5
- 235000008434 ginseng Nutrition 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 4
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 claims description 4
- BYUQATUKPXLFLZ-UIOOFZCWSA-N CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 BYUQATUKPXLFLZ-UIOOFZCWSA-N 0.000 claims description 4
- KNFLNGRLKALWRF-LDXSYGEZSA-N CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)CC1=CC=CC=C1 Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)CC1=CC=CC=C1 KNFLNGRLKALWRF-LDXSYGEZSA-N 0.000 claims description 4
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 4
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 4
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 4
- 244000199866 Lactobacillus casei Species 0.000 claims description 4
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 4
- 240000007575 Macadamia integrifolia Species 0.000 claims description 4
- 235000018330 Macadamia integrifolia Nutrition 0.000 claims description 4
- 235000003800 Macadamia tetraphylla Nutrition 0.000 claims description 4
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 claims description 4
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 claims description 4
- 235000012000 cholesterol Nutrition 0.000 claims description 4
- 229920002674 hyaluronan Polymers 0.000 claims description 4
- 229960003160 hyaluronic acid Drugs 0.000 claims description 4
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 4
- 229940017800 lactobacillus casei Drugs 0.000 claims description 4
- 239000010466 nut oil Substances 0.000 claims description 4
- 229940093441 palmitoyl oligopeptide Drugs 0.000 claims description 4
- 229940101267 panthenol Drugs 0.000 claims description 4
- 235000020957 pantothenol Nutrition 0.000 claims description 4
- 239000011619 pantothenol Substances 0.000 claims description 4
- IHRKJQSLKLYWBQ-QKDODKLFSA-N (2s)-2-[[(2s)-1-[(2s)-5-amino-2-[[2-(hexadecanoylamino)acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O IHRKJQSLKLYWBQ-QKDODKLFSA-N 0.000 claims description 3
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 3
- 241000186012 Bifidobacterium breve Species 0.000 claims description 3
- 241001608472 Bifidobacterium longum Species 0.000 claims description 3
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 3
- 241000186660 Lactobacillus Species 0.000 claims description 3
- 240000001929 Lactobacillus brevis Species 0.000 claims description 3
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims description 3
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 3
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 3
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 3
- 241000186606 Lactobacillus gasseri Species 0.000 claims description 3
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 3
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 3
- 235000002789 Panax ginseng Nutrition 0.000 claims description 3
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 3
- 229940004120 bifidobacterium infantis Drugs 0.000 claims description 3
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 3
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 claims description 3
- QMIFIFIYYPUVNU-ACMTZBLWSA-L copper (2S)-6-amino-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-imidazol-1-id-4-ylpropanoyl]amino]hexanoate Chemical compound [Cu+2].NCCCC[C@@H](C([O-])=O)NC(=O)[C@@H](NC(=O)CN)CC1=C[N-]C=N1 QMIFIFIYYPUVNU-ACMTZBLWSA-L 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 229940039696 lactobacillus Drugs 0.000 claims description 3
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 3
- 229940012969 lactobacillus fermentum Drugs 0.000 claims description 3
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 3
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 3
- 229940094946 palmitoyl tetrapeptide-7 Drugs 0.000 claims description 3
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 2
- 230000037303 wrinkles Effects 0.000 abstract description 13
- 206010040880 Skin irritation Diseases 0.000 abstract description 7
- 230000036556 skin irritation Effects 0.000 abstract description 7
- 231100000475 skin irritation Toxicity 0.000 abstract description 7
- 239000004615 ingredient Substances 0.000 abstract description 6
- 210000003491 skin Anatomy 0.000 description 52
- 230000000694 effects Effects 0.000 description 19
- 238000002360 preparation method Methods 0.000 description 14
- 238000000605 extraction Methods 0.000 description 12
- 102000016942 Elastin Human genes 0.000 description 9
- 108010014258 Elastin Proteins 0.000 description 9
- 229920002549 elastin Polymers 0.000 description 9
- 102000008186 Collagen Human genes 0.000 description 8
- 108010035532 Collagen Proteins 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 229920001436 collagen Polymers 0.000 description 8
- 238000000855 fermentation Methods 0.000 description 8
- 244000146462 Centella asiatica Species 0.000 description 7
- 235000004032 Centella asiatica Nutrition 0.000 description 7
- 210000002615 epidermis Anatomy 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 229920002385 Sodium hyaluronate Polymers 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 229940010747 sodium hyaluronate Drugs 0.000 description 6
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 210000004207 dermis Anatomy 0.000 description 5
- 210000004177 elastic tissue Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000003809 water extraction Methods 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 235000018185 Betula X alpestris Nutrition 0.000 description 3
- 235000018212 Betula X uliginosa Nutrition 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 240000000691 Houttuynia cordata Species 0.000 description 3
- 235000013719 Houttuynia cordata Nutrition 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 3
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- 240000008620 Fagopyrum esculentum Species 0.000 description 2
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 2
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 241000186675 Weissella confusa Species 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 2
- 229940022757 asiaticoside Drugs 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000036620 skin dryness Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- MFYAQFYIDXXKQG-MLCQCVOFSA-N (2s)-2-[[(2s)-4-amino-2-[[(2s)-2-[[(2s)-2-(hexadecanoylamino)-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]amino]propanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O MFYAQFYIDXXKQG-MLCQCVOFSA-N 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- BNMGUJRJUUDLHW-HCZMHFOYSA-N Madecassoside Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(C[C@@H](O)[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O BNMGUJRJUUDLHW-HCZMHFOYSA-N 0.000 description 1
- BNMGUJRJUUDLHW-HLUHVYOBSA-N Madecassoside Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@@]34C)[C@@H]2[C@H]1C)C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O BNMGUJRJUUDLHW-HLUHVYOBSA-N 0.000 description 1
- 108010075308 N-palmitoyl-seryl-seryl-asparaginyl-alanine Proteins 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 1
- 229940011658 asiatic acid Drugs 0.000 description 1
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000036570 collagen biosynthesis Effects 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- VEVRNHHLCPGNDU-MUGJNUQGSA-O desmosine Chemical compound OC(=O)[C@@H](N)CCCC[N+]1=CC(CC[C@H](N)C(O)=O)=C(CCC[C@H](N)C(O)=O)C(CC[C@H](N)C(O)=O)=C1 VEVRNHHLCPGNDU-MUGJNUQGSA-O 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- RGXCTRIQQODGIZ-UHFFFAOYSA-O isodesmosine Chemical compound OC(=O)C(N)CCCC[N+]1=CC(CCC(N)C(O)=O)=CC(CCC(N)C(O)=O)=C1CCCC(N)C(O)=O RGXCTRIQQODGIZ-UHFFFAOYSA-O 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- BUWCHLVSSFQLPN-UHFFFAOYSA-N madecassic acid Natural products CC1CCC2(CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(C5CCC34C)C(=O)O)C2C1C)C(=O)OC6OC(COC7OC(CO)C(OC8OC(C)C(O)C(O)C8O)C(O)C7O)C(O)C(O)C6O BUWCHLVSSFQLPN-UHFFFAOYSA-N 0.000 description 1
- PRAUVHZJPXOEIF-AOLYGAPISA-N madecassic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2[C@H](O)C[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C PRAUVHZJPXOEIF-AOLYGAPISA-N 0.000 description 1
- 229940011656 madecassic acid Drugs 0.000 description 1
- 229940090813 madecassoside Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000001724 microfibril Anatomy 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- -1 pack Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 239000000917 skin toxin Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Abstract
본 발명은 천연추출물이 함유된 피부탄력 개선용 화장료 조성물에 관한 것으로, 더욱 상세하게는 정제수, 보습제, 피부컨디셔닝제 및 피부탄력개선제로 이루어지며, 상기 피부탄력개선제는 에델바이스 추출물이 함유된 펩타이드로 이루어진다.
상기의 성분으로 이루어지는 피부탄력 개선용 화장료 조성물은 피부탄력개선제로 천연추출물이 사용되어 피부탄력 및 피부주름을 개선하면서도 피부자극이 적고, 피부진정 및 피부보습 효과를 나타낸다. The present invention relates to a cosmetic composition for improving skin elasticity containing natural extracts, and more specifically, it consists of purified water, a moisturizer, a skin conditioning agent, and a skin elasticity improving agent, and the skin elasticity improving agent consists of a peptide containing edelweiss extract. .
The cosmetic composition for improving skin elasticity consisting of the above ingredients uses natural extracts as a skin elasticity improving agent, improves skin elasticity and skin wrinkles, causes less skin irritation, and exhibits skin soothing and skin moisturizing effects.
Description
본 발명은 천연추출물이 함유된 피부탄력 개선용 화장료 조성물에 관한 것으로, 더욱 상세하게는 피부탄력개선제로 천연추출물이 사용되어 피부탄력 및 피부주름을 개선하면서도 피부자극이 적고, 피부진정 및 피부보습 효과를 나타내는 천연추출물이 함유된 피부탄력 개선용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for improving skin elasticity containing natural extracts. More specifically, natural extracts are used as skin elasticity improving agents to improve skin elasticity and skin wrinkles while causing less skin irritation and providing skin soothing and skin moisturizing effects. It relates to a cosmetic composition for improving skin elasticity containing natural extracts representing.
피부는 몸을 보호해주고 외부로부터 자극을 받으면 느낄 수 있는 신경말단이 위치해 있으며 체온 조절, 비타민 합성 등의 화학적 및 물리적 반응이 이루어지는 기능도 담당하고 있다.The skin protects the body, contains nerve endings that can sense stimulation from the outside, and is also responsible for chemical and physical reactions such as temperature regulation and vitamin synthesis.
피부는 크게 표피, 진피 및 피하조직으로 구분되며, 진피는 표피보다 수분이 많으며 표피에 영양을 공급해 준다. 표피에 영양이나 수분이 부족해지면 진피에서 수분과 영양을 공급하여 주기 때문에 표피층이 외부로부터 수분을 빼앗기지 않도록 피부보호와 수분을 공급해야 한다. 표피층에 수분 공급이 원활하지 않으면 피부 건조현상이 일어나면서 각질 세포의 결합력이 감소하여 각질층을 포함한 표피 그리고 진피의 수분 밸런스에 영양을 주게 되는데, 이러한 영향을 줄이기 위해서는 피부를 보호하고 수분과 영양을 충분히 공급해야 건강한 피부를 유지할 수 있다.The skin is largely divided into the epidermis, dermis, and subcutaneous tissue. The dermis has more moisture than the epidermis and supplies nutrition to the epidermis. When the epidermis lacks nutrients or moisture, the dermis supplies moisture and nutrients, so skin protection and moisture must be provided to prevent the epidermis layer from losing moisture from the outside. If the supply of moisture to the epidermal layer is not smooth, skin drying occurs and the cohesion of keratinocytes decreases, which nourishes the moisture balance of the epidermis and dermis, including the stratum corneum. To reduce this effect, protect the skin and provide sufficient moisture and nutrients. You must supply it to maintain healthy skin.
특히, 피부는 보이는 부분으로 미적 아름다움을 결정하는데 많은 비중을 차지하기 때문에 피부 보습 유지는 필수적이며, 피부 보습이 부족하면 대부분은 피부가 건조하다고 표현한다. 하지만, 피부 건조현상이 무조건 피부 수분함량의 감소로 인해 발생하는 것이 아니며. 피부 건조현상은 피부가 건조함을 느낄 때 보습제를 수시로 도포하면 건조현상이 개선되는 것으로 보고되고 있다.In particular, the skin is a visible part and plays a large part in determining aesthetic beauty, so keeping the skin moisturized is essential. If the skin is not moisturized, most people say that the skin is dry. However, skin dryness is not necessarily caused by a decrease in skin moisture content. It has been reported that skin dryness is improved by frequently applying moisturizer when the skin feels dry.
한편, 피부탄력은 진피층에 존재하는 엘라스틴(elastin)으로 구성된 탄력섬유에 의해 나타나는데, 이러한 탄력섬유는 고무와 같이 매우 낮은 탄성계수를 가지고 있어서, 작은 힘에 의해서도 쉽게 변형되고, 또 그 힘이 제거되었을 때는 쉽게 원형으로 되돌아 온다. 또한, 탄력섬유는 엘라스틴이라는 무정형의 기질에 미원섬유(microfibrils)들이 박혀 있는 형태를 띠고 있으며, 엘라스틴은 리신에서 유래한 데스모신(desmosine)과 아이소데스모신(isodesmosine)이라는 탄력섬유에서만 발견되는 아주 독특한 아미노산으로 구성된 단백질이다. 이러한 데스모신과 아이소데스모신 등은 긴 펩타이드 사슬안에서 가교(cross-links)를 형성하고 있는데, 이러한 구조가 엘라스틴으로 하여금 고무와 같은 성질을 갖게 한다.Meanwhile, skin elasticity is achieved by elastic fibers composed of elastin present in the dermal layer. These elastic fibers, like rubber, have a very low elastic modulus, so they are easily deformed by even a small force, and can be easily deformed when the force is removed. It easily returns to its original state. In addition, elastic fibers have microfibrils embedded in an amorphous matrix called elastin, and elastin is a very unique material found only in elastic fibers called desmosine and isodesmosine, which are derived from lysine. It is a protein composed of amino acids. These desmosins and isodesmosins form cross-links within long peptide chains, and this structure gives elastin rubber-like properties.
또한, 엘라스틴으로 구성된 탄력섬유는 콜라겐(collagen)이라고 하는 교원섬유와 함께 존재하는데, 엘라스틴과 콜라겐이 충분히 존재하는 상태에서 피부 탄력유지가 가능하다.In addition, elastic fibers composed of elastin exist together with collagen fibers called collagen, and it is possible to maintain skin elasticity when sufficient elastin and collagen are present.
그러나, 노화와 자외선 등에 의한 피부세포(섬유아세포)의 약화로 엘라스틴의 생성저하 및 파괴가 진행되어 피부탄력 저하가 유발될 수 있는데, 자외선 등에 의해 피부내에 엘라스틴 분해효소가 발현되며 이 효소는 피부내의 정상적인 엘라스틴을 분해하여 피부 탄력저하를 유발한다.However, due to aging and weakening of skin cells (fibroblasts) caused by ultraviolet rays, the production and destruction of elastin progresses, which can lead to a decrease in skin elasticity. Elastin-decomposing enzymes are expressed in the skin by ultraviolet rays, etc., and this enzyme is activated in the skin. It breaks down normal elastin, causing loss of skin elasticity.
또한, 피부 탄력저하는 피부 진피의 70% 이상을 구성하는 콜라겐이라는 단백질의 손상 및 생성저하에 의해서도 발생되는데, 콜라겐 역시 자외선 등에 의해 유발되는 콜라게나제(collagenase)라는 분해효소에 의해 분해된다.In addition, decreased skin elasticity is also caused by damage and decreased production of a protein called collagen, which makes up more than 70% of the skin dermis. Collagen is also broken down by a decomposing enzyme called collagenase caused by ultraviolet rays, etc.
종래에는 상기의 문제점을 해소하기 위해 엘라스틴이나 콜라겐의 손상을 억제하거나 생성을 증진시키는 합성성분이 함유된 화장료가 적용되었으나, 종래에 합성성분은 피부가 민감한 사용자로 하여금 피부자극을 유발하는 문제점이 있었다.In the past, cosmetics containing synthetic ingredients that inhibit damage or enhance the production of elastin or collagen were used to solve the above problems. However, in the past, synthetic ingredients had the problem of causing skin irritation in users with sensitive skin. .
본 발명의 목적은 피부탄력개선제로 천연추출물이 사용되어 피부탄력 및 피부주름을 개선하면서도 피부자극이 적고, 피부진정 및 피부보습 효과를 나타내는 천연추출물이 함유된 피부탄력 개선용 화장료 조성물을 제공하는 것이다.The purpose of the present invention is to provide a cosmetic composition for improving skin elasticity containing natural extracts that improve skin elasticity and skin wrinkles by using natural extracts as a skin elasticity improving agent, while causing less skin irritation and exhibiting skin soothing and skin moisturizing effects. .
본 발명의 목적은 정제수, 보습제, 피부컨디셔닝제 및 피부탄력개선제로 이루어지며, 상기 피부탄력개선제는 에델바이스 추출물이 함유된 펩타이드로 이루어지는 것을 특징으로 하는 천연추출물이 함유된 피부탄력 개선용 화장료 조성물을 제공함에 의해 달성된다.The object of the present invention is to provide a cosmetic composition for improving skin elasticity containing natural extracts, which consists of purified water, a moisturizer, a skin conditioning agent, and a skin elasticity improving agent, wherein the skin elasticity improving agent consists of a peptide containing edelweiss extract. is achieved by
본 발명의 바람직한 특징에 따르면, 상기 천연추출물이 함유된 화장료 조성물은 정제수 100 중량부, 보습제 5 내지 20 중량부, 피부컨디셔닝제 1 내지 5 중량부 및 피부탄력개선제 0.1 내지 1 중량부로 이루어지는 것으로 한다.According to a preferred feature of the present invention, the cosmetic composition containing the natural extract is composed of 100 parts by weight of purified water, 5 to 20 parts by weight of a moisturizer, 1 to 5 parts by weight of a skin conditioning agent, and 0.1 to 1 part by weight of a skin elasticity improver.
본 발명의 더 바람직한 특징에 따르면, 상기 보습제는 글리세린, 트루로즈오브예리코추출물, 소듐하이알루로네이트, 베타-글루칸, 하이드롤라이즈드소듐하이알루로네이트, 하이드롤라이즈드하이알루로닉애씨드, 2,3-부탄다이올, 자작나무수액, 스쿠알란 및 베타인으로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것으로 한다.According to a more preferred feature of the present invention, the moisturizing agent includes glycerin, true rose of Jericho extract, sodium hyaluronate, beta-glucan, hydrolyzed sodium hyaluronate, hydrolyzed hyaluronic acid, It shall be composed of one or more selected from the group consisting of 2,3-butanediol, birch sap, squalane, and betaine.
본 발명의 더욱 바람직한 특징에 따르면, 상기 피부컨디셔닝제는 병풀 추출물, 세라마이드엔피, 퀸즈랜드넛오일, 판테놀, 약모밀 추출물 및 콜레스테롤로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것으로 한다.According to a more preferred feature of the present invention, the skin conditioning agent is composed of one or more selected from the group consisting of centella asiatica extract, ceramide NP, Queensland nut oil, panthenol, herbal extract, and cholesterol.
본 발명의 더욱 더 바람직한 특징에 따르면, 상기 피부탄력개선제는 에델바이스 추출물 100 중량부 및 펩타이드 10 내지 30 중량부로 이루어지며, 상기 펩타이드는 아세틸헥사펩타이드-30, 노나펩타이드-1, 아세틸헥사펩타이드-8, 카퍼트라이펩타이드-1, 트라이펩타이드-1, 팔미토일테트라펩타이드-7 및 팔미토일트라이펩타이드-1로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것으로 한다.According to an even more preferred feature of the present invention, the skin elasticity improving agent consists of 100 parts by weight of edelweiss extract and 10 to 30 parts by weight of peptides, and the peptides include acetylhexapeptide-30, nonapeptide-1, acetylhexapeptide-8, It shall be composed of one or more selected from the group consisting of copper tripeptide-1, tripeptide-1, palmitoyl tetrapeptide-7, and palmitoyl tripeptide-1.
본 발명의 더욱 더 바람직한 특징에 따르면, 상기 천연추출물이 함유된 피부탄력 개선용 화장료 조성물에는 상기 정제수 100 중량부 대비 한약재 발효물 0.1 내지 0.5 중량부가 더 함유되며, 상기 한약재 발효물은 한약재 추출물 100 중량부에 유산균 0.01 내지 0.1 중량부를 접종하고 30 내지 45℃의 온도에서 24시간 내지 60시간 동안 발효하여 제조되고, 상기 한약재는 자리공 뿌리, 새삼 씨 및 홍삼으로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것으로 한다.According to an even more preferred feature of the present invention, the cosmetic composition for improving skin elasticity containing the natural extract further contains 0.1 to 0.5 parts by weight of fermented herbal medicine compared to 100 parts by weight of the purified water, and the fermented herbal medicine is 100 parts by weight of herbal extract. It is manufactured by inoculating 0.01 to 0.1 parts by weight of lactic acid bacteria into the body and fermenting for 24 to 60 hours at a temperature of 30 to 45 ° C.
본 발명의 더욱 더 바람직한 특징에 따르면, 상기 한약재 추출물은 덖음된 한약재 100 중량부에 정제수 800 내지 1200 중량부를 혼합하고 80 내지 90℃의 온도로 2 내지 4시간 동안 가열하여 제조되며, 상기 덖음은 60 내지 80℃의 온도에서 10 내지 20분 동안 이루어지는 것으로 한다.According to an even more preferred feature of the present invention, the herbal medicine extract is prepared by mixing 100 parts by weight of the roasted herbal medicine with 800 to 1,200 parts by weight of purified water and heating at a temperature of 80 to 90 ° C. for 2 to 4 hours, and the roasting is 60 This is done for 10 to 20 minutes at a temperature of 80°C.
본 발명의 더욱 더 바람직한 특징에 따르면, 상기 유산균은 락토바실러스 플란타룸, 락토바실러스 가세리, 비피도박테리움 비피덤, 락토바실러스 아시도필루스, 락토바실러스 카제이, 락토바실러스 불가리쿠스, 락토바실러스 람노서스, 락토바실러스 루테리, 락토바실러스 컨퓨서스, 락토바실러스 퍼멘툼, 락토바실러스 브레비스, 비피도박테리움 브레베, 비피도박테리움 롱검 및 비피도박테리움 인판티스로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것으로 한다.According to an even more preferred feature of the present invention, the lactic acid bacteria are Lactobacillus plantarum, Lactobacillus gasseri, Bifidobacterium bifidum, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus bulgaricus, Lactobacillus Consisting of one or more selected from the group consisting of Rhamnosus, Lactobacillus reuteri, Lactobacillus confusus, Lactobacillus fermentum, Lactobacillus brevis, Bifidobacterium breve, Bifidobacterium longum and Bifidobacterium infantis. do.
본 발명에 따른 천연추출물이 함유된 피부탄력 개선용 화장료 조성물은 피부탄력개선제로 천연추출물이 사용되어 피부탄력 및 피부주름을 개선하면서도 피부자극이 적고, 피부진정 및 피부보습 효과를 나타내는 화장료 조성물을 제공하는 탁월한 효과를 나타낸다.The cosmetic composition for improving skin elasticity containing natural extracts according to the present invention uses natural extracts as a skin elasticity improving agent, providing a cosmetic composition that improves skin elasticity and skin wrinkles while causing less skin irritation and exhibiting skin soothing and skin moisturizing effects. It shows excellent effects.
이하에는, 본 발명의 바람직한 실시예와 각 성분의 물성을 상세하게 설명하되, 이는 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 발명을 용이하게 실시할 수 있을 정도로 상세하게 설명하기 위한 것이지, 이로 인해 본 발명의 기술적인 사상 및 범주가 한정되는 것을 의미하지는 않는다.Below, preferred embodiments of the present invention and the physical properties of each component are described in detail, but the purpose is to provide a detailed description so that a person skilled in the art can easily carry out the invention. This does not mean that the technical idea and scope of the present invention are limited.
본 발명에 따른 천연추출물이 함유된 피부탄력 개선용 화장료 조성물은 정제수, 보습제, 피부컨디셔닝제 및 피부탄력개선제로 이루어지며, 정제수 100 중량부, 보습제 5 내지 20 중량부, 피부컨디셔닝제 1 내지 5 중량부 및 피부탄력개선제 0.1 내지 1 중량부로 이루어지는 것이 바람직하다.The cosmetic composition for improving skin elasticity containing natural extracts according to the present invention consists of purified water, a moisturizer, a skin conditioning agent, and a skin elasticity improving agent, including 100 parts by weight of purified water, 5 to 20 parts by weight of moisturizer, and 1 to 5 parts by weight of skin conditioning agent. It is preferable that it consists of 0.1 to 1 part by weight of skin elasticity improving agent.
상기 보습제는 5 내지 20 중량부가 함유되며, 글리세린, 트루로즈오브예리코추출물, 소듐하이알루로네이트, 베타-글루칸, 하이드롤라이즈드소듐하이알루로네이트, 하이드롤라이즈드하이알루로닉애씨드, 2,3-부탄다이올, 자작나무수액, 스쿠알란 및 베타인으로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는데, 본 발명을 통해 제조되는 화장료 조성물에 보습효과를 부여하는 역할을 한다.The moisturizer contains 5 to 20 parts by weight, glycerin, true rose of Jericho extract, sodium hyaluronate, beta-glucan, hydrolyzed sodium hyaluronate, hydrolyzed hyaluronic acid, 2 It consists of one or more selected from the group consisting of 3-butanediol, birch sap, squalane, and betaine, and serves to impart a moisturizing effect to the cosmetic composition prepared through the present invention.
상기 보습제의 함량이 5 중량부 미만이면 상기의 효과가 미미하며, 상기 보습제의 함량이 20 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 화장료 조성물의 끈적임이 지나치게 증가하며, 상대적으로 피부컨디셔닝제 및 피부탄력개선제의 함량이 지나치게 저하되어 화장료 조성물의 기능성이 저하될 수 있기 때문에 바람직하지 못하다.If the content of the moisturizer is less than 5 parts by weight, the effect is minimal, and if the content of the moisturizer exceeds 20 parts by weight, the effect is not significantly improved and the stickiness of the cosmetic composition increases excessively, and relatively skin conditioning This is undesirable because the content of the agent and skin elasticity improving agent may be excessively reduced, thereby reducing the functionality of the cosmetic composition.
상기 피부컨디셔닝제는 1 내지 5 중량부가 함유되며, 병풀 추출물, 세라마이드엔피, 퀸즈랜드넛오일, 판테놀, 약모밀 추출물 및 콜레스테롤로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것이 바람직한데, 피부 진정 및 피부 장벽 보호 효과를 나타낸다.The skin conditioning agent contains 1 to 5 parts by weight, and is preferably composed of one or more selected from the group consisting of centella asiatica extract, ceramide NP, Queensland nut oil, panthenol, herbal extract, and cholesterol, and has a skin soothing and skin barrier protection effect. indicates.
상기 병풀 추출물과 약모밀 추출물은 병풀과 약모밀을 완전 건조한 후 추출하는데, 추출방법은 여과법, 열수 추출, 침지 추출, 환류 냉각 추출 및 초음파 추출 등의 당업계에 공지된 모든 통상적인 방법을 사용할 수 있다. 추출용매는 건조된 병풀 추출물 및 약모밀 추출물 대비 5 내지 10배로 첨가하는 것이 바람직하지만 이에 한정되지 않는다. 또한 추출온도는 40 내지 50℃, 추출시간은 4 내지 6시간 동안 이루어지는 것이 바람직하다.The Centella asiatica extract and the medicinal root extract are extracted after completely drying the centella asiatica and the medicinal root extract. The extraction method may be any conventional method known in the art, such as filtration, hot water extraction, immersion extraction, reflux cooling extraction, and ultrasonic extraction. The extraction solvent is preferably added at 5 to 10 times the amount compared to the dried Centella asiatica extract and medicinal root extract, but is not limited to this. Additionally, the extraction temperature is preferably 40 to 50°C and the extraction time is preferably 4 to 6 hours.
상기 병풀(Centella asiatica)은 쌍떡잎식물로 미나리과의 여러해살이 식물로 덩굴이나 뿌리가 땅 위로 길게 뻗으며 자라나는 포복성 식물이다. 우리나라에서는 ‘병을 치료하는 식물’이라 해서 병풀로 불리우며, 중국, 인도 등에서는 수명 연장 및 에너지 약초로 널리 사용되어지고 있다. 병풀의 효능으로 피부 상처, 만성 궤양, 관절염, 나병의 치료, 해열제, 이뇨제, 강장제 등이 보고되어 있고, 혈관 강화 및 혈액 순환 촉진 기능을 갖고 있으며, 체내 노폐물을 원화하게 배설해 준다. 병풀이 가지고 있는 대표적인 유효 성분은 아시아틱산(Asiatic acid), 아시아티코사이드(Asiaticoside), 마데카식산 (Madecassic acid), 마데카소사이드(Madecassocide)의 총 4가지 성분으로 이들은 피부 재생과 콜라겐 합성 촉진 능력을 지닌다. 특히, 아시아티코사이드(Asiaticoside)는 항균 및 항진균 활성에 있어 탁월한 효과를 지닌다. Centella asiatica is a dicotyledonous plant and a perennial plant of the Apiaceae family. It is a creeping plant with vines or roots extending long above the ground. In Korea, it is called Centella asiatica because it is a 'plant that cures diseases', and in China and India, it is widely used as a life extension and energy herb. Centella asiatica has been reported to be effective in treating skin wounds, chronic ulcers, arthritis, and leprosy, as an antipyretic, diuretic, and tonic. It has the function of strengthening blood vessels and promoting blood circulation, and excretes waste products from the body. The representative active ingredients of Centella asiatica are four ingredients: Asiatic acid, Asiaticoside, Madecassic acid, and Madecassoside. These have the ability to promote skin regeneration and collagen synthesis. has In particular, Asiaticoside has excellent antibacterial and antifungal effects.
또한, 상기 약모밀(Houttuynia cordata THUNB.)은 삼백초과의 여러해살이풀로, 단형 속인 약모밀속을 구성하는 유일한 종이다. 잎과 줄기에서 고기 비린내와 같은 냄새가 나기 때문에 어성초라고도 부른다. 중약초, 즙채, 십약 등의 여러 이름을 가지고 있다. 약모밀에는 피부의 독성을 제거하는 쿠에르치트린 성분이 풍부하여 소염 작용을 통해 모공을 깨끗이하고 피부트러블 완화에 도움을 준다. 예로부터 해독작용이 뛰어난 약초로 알려져 있다.In addition, Houttuynia cordata THUNB. is a perennial herb of the Tricetaceae family and is the only species constituting the monotypic genus Houttuynia cordata THUNB. It is also called Houttuynia cordata because its leaves and stems emit a fishy smell like meat. It has several names such as Chinese herb, japchae, and ten herbs. Yammil is rich in quercitrin, an ingredient that removes skin toxins, and helps clean pores and relieve skin problems through its anti-inflammatory action. It has been known since ancient times as an herb with excellent detoxification properties.
상기 피부컨디셔닝제의 함량이 1 중량부 미만이면 상기의 효과가 미미하며, 상기 피부컨디셔닝제의 함량이 5 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 상대적으로 보습제나 피부탄력개선제의 함량이 지나치게 줄어들어 화장료 조성물의 기능성이 저하될 수 있기 때문에 바람직하지 못하다.If the content of the skin conditioning agent is less than 1 part by weight, the effect is minimal, and if the content of the skin conditioning agent exceeds 5 parts by weight, the effect is not significantly improved, but the content of the moisturizer or skin elasticity improver is relatively high. This is undesirable because excessive reduction may reduce the functionality of the cosmetic composition.
상기 피부탄력개선제는 0.1 내지 1 중량부가 함유되며, 에델바이스 추출물이 함유된 펩타이드로 이루어지는데, 에델바이스 추출물 100 중량부 및 펩타이드 10 내지 30 중량부로 이루어지는 것이 바람직하다.The skin elasticity improving agent contains 0.1 to 1 part by weight and consists of a peptide containing edelweiss extract, and is preferably composed of 100 parts by weight of edelweiss extract and 10 to 30 parts by weight of peptide.
상기 에델바이스 추출물은 에델바이스 꽃을 완전 건조한 후 추출하는데, 추출방법은 여과법, 열수 추출, 침지 추출, 환류 냉각 추출 및 초음파 추출 등의 당업계에 공지된 모든 통상적인 방법을 사용할 수 있다. 추출용매는 건조된 에델바이스 꽃 대비 5 내지 10배로 첨가하는 것이 바람직하지만 이에 한정되지 않는다. 또한 추출온도는 40 내지 50℃, 추출시간은 4 내지 6시간 동안 이루어지는 것이 바람직하다.The edelweiss extract is extracted after completely drying the edelweiss flowers, and all conventional methods known in the art can be used, such as filtration, hot water extraction, immersion extraction, reflux cooling extraction, and ultrasonic extraction. It is preferable to add the extraction solvent in an amount of 5 to 10 times that of dried edelweiss flowers, but it is not limited to this. Additionally, the extraction temperature is preferably 40 to 50°C and the extraction time is preferably 4 to 6 hours.
상기의 과정을 통해 제조되는 에델바이스 추출물은 천연 안티 에이징의 효능을 내는 천연 노화방지제이며 혈액순환 증진을 통해 피부가 세포 생성을 활성화 할 수 있게 하기 때문에, 피부 노화를 방지하고 피부탄력을 개선하는 역할을 한다.The edelweiss extract manufactured through the above process is a natural anti-aging agent that produces natural anti-aging effects. It helps the skin activate cell production by improving blood circulation, thus preventing skin aging and improving skin elasticity. do.
또한, 상기 펩타이드는 에델바이스 추출물 100 중량부 대비 10 내지 30 중량부가 함유되는데, 아세틸헥사펩타이드-30, 노나펩타이드-1, 아세틸헥사펩타이드-8, 카퍼트라이펩타이드-1, 트라이펩타이드-1, 팔미토일테트라펩타이드-7 및 팔미토일트라이펩타이드-1로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것이 바람직한데, 상기의 성분으로 이루어지는 펩타이드는 분자량이 작아 피부탄력 개선효과가 우수하다.In addition, the peptide contains 10 to 30 parts by weight based on 100 parts by weight of the edelweiss extract, including acetylhexapeptide-30, nonapeptide-1, acetylhexapeptide-8, copper tripeptide-1, tripeptide-1, and palmitoyl tetrapeptide. It is preferably composed of one or more selected from the group consisting of peptide-7 and palmitoyl tripeptide-1. The peptide composed of the above components has a low molecular weight and is excellent in improving skin elasticity.
상기 피부탄력개선제의 함량이 0.1 중량부 미만이면 상기의 효과가 미미하며, 상기 피부탄력개선제의 함량이 1 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 제조비용을 지나치게 증가시키기 때문에 바람직하지 못하다.If the content of the skin elasticity improver is less than 0.1 part by weight, the effect is minimal, and if the content of the skin elasticity improver exceeds 1 part by weight, the effect is not significantly improved and the manufacturing cost is excessively increased, which is not desirable. Can not do it.
또한, 본 발명에 따른 천연추출물이 함유된 피부탄력 개선용 화장료 조성물에는 상기 정제수 100 중량부 대비 한약재 발효물 0.1 내지 0.5 중량부가 더 함유될 수도 있다.In addition, the cosmetic composition for improving skin elasticity containing natural extracts according to the present invention may further contain 0.1 to 0.5 parts by weight of fermented herbal medicine compared to 100 parts by weight of the purified water.
상기 한약재 발효물은 한약재 추출물 100 중량부에 유산균 0.01 내지 0.1 중량부를 접종하고 30 내지 45℃의 온도에서 24시간 내지 60시간 동안 발효하여 제조되고, 상기 한약재는 자리공 뿌리, 새삼 씨 및 홍삼으로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것이 바람직하다.The fermented herbal medicine is prepared by inoculating 0.01 to 0.1 parts by weight of lactic acid bacteria in 100 parts by weight of herbal extract and fermenting for 24 to 60 hours at a temperature of 30 to 45 ° C. It is preferable that it consists of one or more selected from.
상기와 같이 자리공 뿌리, 새삼 씨 및 홍삼 등으로 이루어지는 한약재를 발효하여 제조된 한약재 추출물은 본 발명을 통해 제조되는 체내 결합조직을 구성하는 콜라겐의 생합성을 증지시켜 섬유아세포에서 매우 강력한 콜라겐 생합성 증진 효과를 나타내어 피부 탄력 및 피부 주름 개선 효과가 월등하게 향상되도록 할 뿐만 아니라, 상처부위에 적용되면 매우 우수한 창상치유 효과를 나타낸다.As described above, the herbal medicine extract prepared by fermenting the herbal medicine consisting of the root, ginseng seed, and red ginseng enhances the biosynthesis of collagen, which constitutes the connective tissue in the body produced through the present invention, and has a very strong collagen biosynthesis enhancing effect in fibroblasts. Not only does it significantly improve skin elasticity and skin wrinkle improvement, but it also has an excellent wound healing effect when applied to the wound area.
이때, 상기 한약재의 덖음의 온도가 60℃ 미만이거나 덖음시간이 5분 미만이면 한약재에 함유된 유효성분의 용출량 증가 효과가 미미하며, 상기 덖음의 온도가 80℃를 초과하거나 덖음시간이 10분을 초과하게 되면 한약재에 함유된 유효성분이 파괴될 수 있기 때문에 바람직하지 못하다.At this time, if the peeling temperature of the herbal medicine is less than 60°C or the peeling time is less than 5 minutes, the effect of increasing the elution amount of the active ingredient contained in the herbal medicine is minimal, and if the baking temperature exceeds 80°C or the peeling time is less than 10 minutes If it is exceeded, it is undesirable because the effective ingredients contained in herbal medicine may be destroyed.
상기의 과정을 통해 제조되는 한약재 추출물은 한약재에 함유된 유효성분의 용출량이 월등하게 향상되면서도, 추출과정에서 유효성분의 파괴가 최소화될 뿐만 아니라, 발효의 과정을 통해 체내 흡수율이 증가되기 때문에 콜라겐의 생합성 증진효과가 더욱 향상된다.The herbal medicine extract produced through the above process significantly improves the elution amount of the active ingredients contained in the herbal medicine, not only minimizes the destruction of the active ingredients during the extraction process, but also increases the absorption rate in the body through the fermentation process, thereby increasing collagen production. The biosynthesis enhancement effect is further improved.
또한, 상기 발효온도가 30℃ 미만이거나 발효시간이 24시간 미만이면 상기 한약재 추출물의 발효가 제대로 진행되지 못하며, 상기 발효온도가 45℃를 초과하거나 발효시간이 60시간을 초과하게 되면 상기의 발효 효과는 크게 향상되지 않으면서 혐기성 발효가 진행되거나 한약재 추출물이 변질될 수 있기 때문에 바람직하지 못하다.In addition, if the fermentation temperature is less than 30°C or the fermentation time is less than 24 hours, the fermentation of the herbal medicine extract does not proceed properly, and if the fermentation temperature exceeds 45°C or the fermentation time exceeds 60 hours, the fermentation effect is reduced. is undesirable because anaerobic fermentation may proceed without significant improvement or the herbal medicine extract may deteriorate.
이때, 상기 유산균은 락토바실러스 플란타룸(Lactobacillus plantarum), 락토바실러스 가세리(Lactobacillus gasseri), 비피도박테리움 비피덤(Bifidobacterium bifidum), 락토바실러스 아시도필루스(Lactobacillus acidophilus), 락토바실러스 카제이(Lactobacillus casei), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus), 락토바실러스 람노서스(Lactobacillus rhamnosus), 락토바실러스 루테리(Lactobacillus reuteri), 락토바실러스 컨퓨서스(Lactobacillus confusus), 락토바실러스 퍼멘툼(Lactobacillus fermentum), 락토바실러스 브레비스(Lactobacillus brevis), 비피도박테리움 브레베(Bifidobacterium breve), 비피도박테리움 롱검(Bifidobacterium longum) 및 비피도박테리움 인판티스(Bifidobacterium infantis)로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것이 바람직하다.At this time, the lactic acid bacteria are Lactobacillus plantarum , Lactobacillus gasseri, Bifidobacterium bifidum, Lactobacillus acidophilus , and Lactobacillus casei. ( Lactobacillus casei ), Lactobacillus bulgaricus , Lactobacillus rhamnosus , Lactobacillus reuteri , Lactobacillus confusus , Lactobacillus fermentum , lactobacillus It is preferably composed of at least one selected from the group consisting of Lactobacillus brevis , Bifidobacterium breve, Bifidobacterium longum , and Bifidobacterium infantis . .
또한, 본 발명에 따른 천연추출물이 함유된 피부탄력 개선용 화장료 조성물에는 알러젠프리 블랙베리향 등의 향료가 더 함유될 수 있으며, 화장료 조성물의 제형은 클랜져, 피부외용연고, 유연화장수, 영양화장수, 영양크림, 마사지크림, 크림 미스트, 에센스, 팩, 에멀젼 및 오일젤 등의 제형으로 적용될 수 있다.In addition, the cosmetic composition for improving skin elasticity containing natural extracts according to the present invention may further contain fragrances such as allergen-free blackberry fragrance, and the formulation of the cosmetic composition is cleanser, external skin ointment, softening lotion, and nourishing lotion. , can be applied in formulations such as nutritional cream, massage cream, cream mist, essence, pack, emulsion, and oil gel.
이하에서는, 본 발명에 따른 천연추출물이 함유된 피부탄력 개선용 화장료 조성물의 제조방법 및 그 제조방법으로 제조된 화장료 조성물의 물성을 실시예를 들어 설명하기로 한다.Hereinafter, a method for manufacturing a cosmetic composition for improving skin elasticity containing natural extracts according to the present invention and the physical properties of the cosmetic composition prepared by the method will be described using examples.
<제조예 1> 병풀 추출물의 제조<Preparation Example 1> Preparation of Centella asiatica extract
병풀 잎을 건조한 후에, 건조된 병풀 잎 100 중량부에 정제수 800 중량부를 혼합하고 45℃의 온도에서 5시간 동안 열수추출하고, 고형분을 제거하여 병풀 추출물을 제조하였다. After drying the Centella asiatica leaves, 800 parts by weight of purified water were mixed with 100 parts by weight of the dried Centella asiatica leaves, subjected to hot water extraction at a temperature of 45°C for 5 hours, and solid content was removed to prepare a Centella asiatica extract.
<제조예 2> 약모밀 추출물의 제조<Preparation Example 2> Preparation of medicinal buckwheat extract
약모밀을 건조한 후에, 건조된 양모밀 100 중량부에 정제수 800 중량부를 혼합하고 45℃의 온도에서 5시간 동안 열수추출하고, 고형분을 제거하여 약모밀 추출물을 제조하였다.After drying the weak hair wheat, 800 parts by weight of purified water was mixed with 100 parts by weight of the dried wool wheat, hot water extraction was performed at a temperature of 45° C. for 5 hours, and solid content was removed to prepare a weak hair extract.
<제조예 3> 에델바이스 추출물의 제조<Preparation Example 3> Preparation of edelweiss extract
에델바이스 꽃잎 건조한 후에, 건조된 에델바이스 꽃잎 100 중량부에 정제수 800 중량부를 혼합하고 45℃의 온도에서 5시간 동안 열수추출하고, 고형분을 제거하여 에델바이스 추출물을 제조하였다.After drying the edelweiss petals, 800 parts by weight of purified water was mixed with 100 parts by weight of the dried edelweiss petals, subjected to hot water extraction at a temperature of 45°C for 5 hours, and solid content was removed to prepare an edelweiss extract.
<제조예 4> 한약재 발효물의 제조<Preparation Example 4> Preparation of fermented herbal medicine products
자리공 뿌리, 새삼 씨 및 홍삼을 1:1:1의 중량부로 혼합하여 이루어진 한약재를 70℃의 온도로 8분 동안 덖음한 후에, 덖음된 한약재 100 중량부에 정제수 800 중량부를 혼합하고 85℃의 온도로 3시간 동안 가열하여 한약재 추출물을 제조하고, 제조된 한약재 추출물 100 중량부에 유산균(락토바실러스 아시도필루스) 0.05 중량부를 접종하고 37℃의 온도에서 42시간 동안 발효하여 한약재 발효물을 제조하였다.Herbal medicine made by mixing 1:1:1 parts by weight of ginseng roots, ginseng seeds, and red ginseng was roasted at a temperature of 70°C for 8 minutes, then 800 parts by weight of purified water were mixed with 100 parts by weight of the roasted herbal medicine, and then roasted at a temperature of 85°C. An herbal medicine extract was prepared by heating for 3 hours, and 0.05 parts by weight of lactic acid bacteria (Lactobacillus acidophilus) was inoculated into 100 parts by weight of the prepared herbal medicine extract and fermented at a temperature of 37° C. for 42 hours to prepare a fermented herbal medicine product. .
<실시예 1><Example 1>
정제수 100 중량부, 보습제(2,3-부탄다이올, 글리세린, 트루로즈오브예리코추출물, 자작나무수액이 1:1:1:1의 중량부로 혼합) 12.5 중량부, 피부컨디셔닝제(상기 제조예 1을 통해 제조된 병풀추출물과 세라마이드엔피가 1:1의 중량부로 혼합) 3 중량부 및 피부탄력개선제(상기 제조예 3을 통해 제조된 에델바이스 추출물100 중량부에 아세틸헥사펩타이드-30 20 중량부가 혼합) 0.5 중량부를 혼합하여 천연추출물이 함유된 피부탄력 개선용 화장료 조성물을 제조하였다.100 parts by weight of purified water, moisturizer (2,3-butanediol, glycerin, true rose of Jericho extract, and birch sap mixed in a ratio of 1:1:1:1 by weight) 12.5 parts by weight, skin conditioning agent (preparation example above) 3 parts by weight of Centella asiatica extract and Ceramide NP prepared through 1 mixed at a ratio of 1:1 by weight) and skin elasticity improver (mixed with 100 parts by weight of edelweiss extract prepared through Preparation Example 3 and 20 parts by weight of Acetylhexapeptide-30) ) 0.5 parts by weight was mixed to prepare a cosmetic composition for improving skin elasticity containing natural extracts.
<실시예 2><Example 2>
정제수 100 중량부, 보습제(스쿠알란, 글리세린, 베타인, 트루로즈오브예리코추출물, 소듐하이알루로네이트, 하이드롤라이즈드소듐하이알루로네이트 및 하이드롤라이즈드하이알루로닉애씨드가 1:1:1:1:1:1:1의 중량부로 혼합) 12.5 중량부, 피부컨디셔닝제(퀸즈랜드넛오일, 판테놀, 상기 제조예 2를 통해 제조된 약모밀추출물, 콜레스테롤 및 세라마이드엔피가 1:1:1:1:1의 중량부로 혼합) 3 중량부 및 피부탄력개선제{상기 제조예 3을 통해 제조된 에델바이스 추출물 100 중량부에 펩타이드(아세틸헥사펩타이드-30, 노나펩타이드-1, 아세틸헥사펩타이드-8, 카퍼트라이펩타이드-1, 트라이펩타이드-1, 팔미토일테트라펩타이드-7 및 팔미토일트라이펩타이드-1가 1:1:1:1:1:1:1의 중량부로 혼합) 20 중량부가 혼합)} 0.5 중량부를 혼합하여 천연추출물이 함유된 피부탄력 개선용 화장료 조성물을 제조하였다.100 parts by weight of purified water, moisturizer (squalane, glycerin, betaine, true rose of Jericho extract, sodium hyaluronate, hydrolyzed sodium hyaluronate and hydrolyzed hyaluronic acid 1:1: (mixed in parts by weight of 1:1:1:1:1) 12.5 parts by weight, skin conditioning agent (Queensland nut oil, panthenol, medicinal buckwheat extract prepared through Preparation Example 2 above, cholesterol and ceramide NP are 1:1:1: (Mixed at a weight ratio of 1:1) 3 parts by weight and skin elasticity improver {100 parts by weight of the edelweiss extract prepared through Preparation Example 3 above, peptides (acetylhexapeptide-30, nonapeptide-1, acetylhexapeptide-8, copper) Tripeptide-1, tripeptide-1, palmitoyl tetrapeptide-7 and palmitoyl tripeptide-1 are mixed in a weight ratio of 1:1:1:1:1:1:1) 20 parts by weight are mixed)} 0.5 weight The parts were mixed to prepare a cosmetic composition for improving skin elasticity containing natural extracts.
<실시예 3><Example 3>
상기 실시예 1과 동일하게 진행하되, 상기 정제수 100 중량부 대비 상기 제조예 4를 통해 제조된 한약재 발효물 0.3 중량부를 더 혼합하여 천연추출물이 함유된 피부탄력 개선용 화장료 조성물을 제조하였다.Proceeding in the same manner as in Example 1, a cosmetic composition for improving skin elasticity containing natural extracts was prepared by mixing 0.3 parts by weight of the fermented herbal medicine prepared through Preparation Example 4 with 100 parts by weight of the purified water.
<실시예 4><Example 4>
상기 실시예 2와 동일하게 진행하되, 상기 정제수 100 중량부 대비 상기 제조예 4를 통해 제조된 한약재 발효물 0.3 중량부를 더 혼합하여 천연추출물이 함유된 피부탄력 개선용 화장료 조성물을 제조하였다.The same procedure as in Example 2 was carried out, but a cosmetic composition for improving skin elasticity containing natural extracts was prepared by mixing 0.3 parts by weight of the fermented herbal medicine prepared through Preparation Example 4 with 100 parts by weight of the purified water.
상기 실시예 1 내지 4를 통해 제조된 천연추출물이 함유된 피부탄력 개선용 화장료 조성물의 피부 탄력 개선, 피부 자극 여부, 피부 진정 및 피부 보습 효과를 측정하여 아래 표 1에 나타내었다.The skin elasticity improvement, skin irritation, skin soothing, and skin moisturizing effects of the cosmetic compositions for improving skin elasticity containing natural extracts prepared through Examples 1 to 4 were measured and are shown in Table 1 below.
{단, 피부 탄력 개선, 피부 자극, 피부 진정 및 피부 보습 효과는 피시험자 50명을 대상으로, 제조된 화장료 조성물 2mL를 하루 2번 12시간 간격으로 얼굴에 도포하는 과정을 30일 동안 진행한 후에 5점 척도법으로 조사하여 평균값으로 나타내는 방법을 이용하였다.{However, the effects of improving skin elasticity, skin stimulation, skin soothing, and skin moisturizing were tested on 50 test subjects after applying 2 mL of the manufactured cosmetic composition to the face twice a day at 12-hour intervals for 30 days. The survey was conducted using a 5-point scale and expressed as an average value.
5점: 매우 개선, 4점: 약간 개선, 3점: 개선 없음, 2점: 악화 1점: 매우 악화}5 points: very improved, 4 points: slightly improved, 3 points: no improvement, 2 points: worsened, 1 point: very worsened}
<표 1><Table 1>
상기 표 1에 나타낸 것처럼, 본 발명의 실시예 1 내지 4를 통해 제조된 화장료 조성물은 피부 탄력 개선, 피부 자극, 피부 진정 및 피부 보습 효과가 우수하며, 특히, 실시예 4를 통해 제조된 화장료 조성물의 기능성이 가장 우수한 것을 알 수 있다.As shown in Table 1, the cosmetic composition prepared through Examples 1 to 4 of the present invention has excellent skin elasticity improvement, skin stimulation, skin soothing, and skin moisturizing effects. In particular, the cosmetic composition prepared through Example 4 It can be seen that the functionality is the best.
또한, 상기 실시예 1 내지 4를 통해 제조된 천연추출물이 함유된 피부탄력 개선용 화장료 조성물의 피부 주름개선 효과를 측정하여 아래 표 2에 나타내었다.In addition, the skin wrinkle improvement effect of the cosmetic composition for improving skin elasticity containing natural extracts prepared through Examples 1 to 4 was measured and shown in Table 2 below.
{단, 피부 주름개선 효과는 6주령의 헤어리스 마우스를 이용하여 광에 의해 유발된 피부 주름에 대한 개선 효과를 측정하는 방법을 이용하였다.{However, the effect of improving skin wrinkles was measured by measuring the effect of improving skin wrinkles caused by light using 6-week-old hairless mice.
상기 실시예 1 내지 4를 통해 제조된 화장료 조성물을 10%로 증류수에 녹여 적용하였으며, 헤어리스 마우스에 태양광선 시뮬레이터(solar simulator)를 이용하여 2MED로 1주일에 3일씩 10주간 조사하여 주름을 형성시키고, 시료를 첨가하지 않은 증류수를 처리한 대조군과 10% 농도의 화장료 조성물을 1일 2회 0.5㎖/㎠(건조추출물로 50mg/㎠)씩 6주간 처리한 군(5개)을 대상으로 주름 개선 정도를 정성 판단하였다.The cosmetic composition prepared through Examples 1 to 4 was dissolved in distilled water at 10% and applied, and hairless mice were irradiated with 2MED using a solar simulator for 10 weeks, 3 days a week to form wrinkles. Wrinkles were tested in a control group treated with distilled water without adding any sample and a group treated with a 10% concentration cosmetic composition twice a day at 0.5 ㎖/㎠ (50 mg/㎠ as dried extract) for 6 weeks (5 groups). The degree of improvement was qualitatively judged.
주름개선 정도의 판단은 시료 처리 부위를 육안과 사진 촬영을 통하여 육안 판정하였고, 판정기준은 각각의 추출물 처리군 및 대조군을 시료 처리전과 비교하여 개선없음, 약간의 개선, 중등도의 개선, 상당한 개선의 4단계로 판정하였다.}The degree of wrinkle improvement was judged visually and by photographing the sample treated area, and the judgment criteria were no improvement, slight improvement, moderate improvement, and significant improvement by comparing each extract treatment group and control group to before sample treatment. It was judged to be level 4.}
<표 2><Table 2>
상기 표 2에 나타낸 것처럼, 본 발명의 실시예 1 내지 4을 통해 제조된 화장료 조성물은 우수한 피부 주름개선 효과를 나타내는 것을 알 수 있으며, 특히, 실시예 4를 통해 제조된 화장료 조서물의 피부 주름개선 효과가 가장 우수한 것을 알 수 있다.As shown in Table 2, it can be seen that the cosmetic compositions prepared through Examples 1 to 4 of the present invention exhibit excellent skin wrinkle improvement effects. In particular, the skin wrinkle improvement effect of the cosmetic composition prepared through Example 4 It can be seen that is the best.
따라서, 본 발명에 따른 천연추출물이 함유된 피부탄력 개선용 화장료 조성물은 피부탄력개선제로 천연추출물이 사용되어 피부탄력을 개선하면서도 피부자극이 적고, 피부진정 및 피부보습 효과를 나타내는 화장료 조성물을 제공한다.Therefore, the cosmetic composition for improving skin elasticity containing natural extracts according to the present invention uses natural extracts as a skin elasticity improving agent, providing a cosmetic composition that improves skin elasticity while causing less skin irritation and exhibiting skin soothing and skin moisturizing effects. .
Claims (8)
상기 보습제는 트루로즈오브예리코추출물, 하이드롤라이즈드하이알루로닉애씨드 및 2,3-부탄다이올로 이루어진 그룹에서 선택된 하나 이상으로 이루어지고,
상기 피부탄력개선제는 에델바이스 추출물 100 중량부 및 펩타이드 10 내지 30 중량부로 이루어지며,
상기 펩타이드는 아세틸헥사펩타이드-30, 노나펩타이드-1, 아세틸헥사펩타이드-8, 카퍼트라이펩타이드-1, 트라이펩타이드-1, 팔미토일테트라펩타이드-7 및 팔미토일트라이펩타이드-1로 이루어진 그룹에서 선택된 하나 이상으로 이루어지고,
상기 한약재 발효물은 한약재 추출물 100 중량부에 유산균 0.01 내지 0.1 중량부를 접종하고 30 내지 45℃의 온도에서 24시간 내지 60시간 동안 발효하여 제조되며,
상기 한약재는 자리공 뿌리, 새삼 씨 및 홍삼으로 이루어지는 것을 특징으로 하는 천연추출물이 함유된 피부탄력 개선용 화장료 조성물.
It consists of 100 parts by weight of purified water, 5 to 20 parts by weight of moisturizer, 1 to 5 parts by weight of skin conditioning agent, 0.1 to 1 part by weight of skin elasticity improver, and 0.1 to 0.5 parts by weight of fermented herbal medicine,
The moisturizing agent consists of one or more selected from the group consisting of true rose of Jericho extract, hydrolyzed hyaluronic acid, and 2,3-butanediol,
The skin elasticity improver consists of 100 parts by weight of edelweiss extract and 10 to 30 parts by weight of peptide,
The peptide is one selected from the group consisting of acetylhexapeptide-30, nonapeptide-1, acetylhexapeptide-8, copper tripeptide-1, tripeptide-1, palmitoyltetrapeptide-7, and palmitoyltripeptide-1. The above is accomplished,
The fermented herbal medicine is prepared by inoculating 0.01 to 0.1 parts by weight of lactic acid bacteria into 100 parts by weight of herbal extract and fermenting for 24 to 60 hours at a temperature of 30 to 45 ° C.
A cosmetic composition for improving skin elasticity containing natural extracts, characterized in that the herbal medicine consists of ginseng roots, ginseng seeds, and red ginseng.
상기 피부컨디셔닝제는 병풀 추출물, 세라마이드엔피, 퀸즈랜드넛오일, 판테놀, 약모밀 추출물 및 콜레스테롤로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것을 특징으로 하는 천연추출물이 함유된 피부탄력 개선용 화장료 조성물.
In claim 1,
The skin conditioning agent is a cosmetic composition for improving skin elasticity containing natural extracts, characterized in that it consists of one or more selected from the group consisting of centella asiatica extract, ceramide NP, Queensland nut oil, panthenol, herbal extract, and cholesterol.
상기 한약재 추출물은 덖음된 한약재 100 중량부에 정제수 800 내지 1200 중량부를 혼합하고 80 내지 90℃의 온도로 2 내지 4시간 동안 가열하여 제조되며,
상기 덖음은 60 내지 80℃의 온도에서 10 내지 20분 동안 이루어지는 것을 특징으로 하는 천연추출물이 함유된 피부탄력 개선용 화장료 조성물.
In claim 1,
The herbal medicine extract is prepared by mixing 100 parts by weight of the roasted herbal medicine with 800 to 1,200 parts by weight of purified water and heating at a temperature of 80 to 90 ° C. for 2 to 4 hours,
A cosmetic composition for improving skin elasticity containing natural extracts, characterized in that the peeling is performed for 10 to 20 minutes at a temperature of 60 to 80 ° C.
상기 유산균은 락토바실러스 플란타룸, 락토바실러스 가세리, 비피도박테리움 비피덤, 락토바실러스 아시도필루스, 락토바실러스 카제이, 락토바실러스 불가리쿠스, 락토바실러스 람노서스, 락토바실러스 루테리, 락토바실러스 컨퓨서스, 락토바실러스 퍼멘툼, 락토바실러스 브레비스, 비피도박테리움 브레베, 비피도박테리움 롱검 및 비피도박테리움 인판티스로 이루어진 그룹에서 선택된 하나 이상으로 이루어지는 것을 특징으로 하는 천연추출물이 함유된 피부탄력 개선용 화장료 조성물.In claim 1,
The lactic acid bacteria include Lactobacillus plantarum, Lactobacillus gasseri, Bifidobacterium bifidum, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus bulgaricus, Lactobacillus rhamnosus, Lactobacillus reuteri, and Lactobacillus confu. Skin elasticity containing natural extracts, characterized in that it consists of one or more selected from the group consisting of Lactobacillus fermentum, Lactobacillus brevis, Bifidobacterium breve, Bifidobacterium longum, and Bifidobacterium infantis. Cosmetic composition for improvement.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230164488A KR102657790B1 (en) | 2023-11-23 | 2023-11-23 | Cosmetic composition for improving skin elasticity containing natural extracts |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230164488A KR102657790B1 (en) | 2023-11-23 | 2023-11-23 | Cosmetic composition for improving skin elasticity containing natural extracts |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102657790B1 true KR102657790B1 (en) | 2024-04-17 |
Family
ID=90876192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020230164488A KR102657790B1 (en) | 2023-11-23 | 2023-11-23 | Cosmetic composition for improving skin elasticity containing natural extracts |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102657790B1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101645238B1 (en) | 2015-11-11 | 2016-08-03 | 강원대학교산학협력단 | Cosmetic composition for anti-wrinkle or elasticity of skin |
KR102016027B1 (en) | 2018-06-04 | 2019-08-29 | 주식회사 익스플즌 | Cosmetics composition improving skin wrinkle and skin elasticity and cosmetics including the same |
KR102193902B1 (en) * | 2012-12-27 | 2020-12-22 | 가부시기가이샤하야시바라 | Skin-exterior anti-ageing composition and production method therefor |
KR102214493B1 (en) * | 2020-07-29 | 2021-02-09 | 진성글로벌 주식회사 | Brass colouring method |
KR20220008484A (en) * | 2020-07-14 | 2022-01-21 | 주식회사 코리아나화장품 | Cosmetic composition for improving skin condition comprising hemp seed oil, plant callus culture filtrate and peptides as active ingredient |
KR20220154918A (en) * | 2021-05-14 | 2022-11-22 | 씨앤알코스메틱스 주식회사 | Cosmetic composition containing Cudrania extract as an active ingredient |
-
2023
- 2023-11-23 KR KR1020230164488A patent/KR102657790B1/en active IP Right Grant
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102193902B1 (en) * | 2012-12-27 | 2020-12-22 | 가부시기가이샤하야시바라 | Skin-exterior anti-ageing composition and production method therefor |
KR101645238B1 (en) | 2015-11-11 | 2016-08-03 | 강원대학교산학협력단 | Cosmetic composition for anti-wrinkle or elasticity of skin |
KR102016027B1 (en) | 2018-06-04 | 2019-08-29 | 주식회사 익스플즌 | Cosmetics composition improving skin wrinkle and skin elasticity and cosmetics including the same |
KR20220008484A (en) * | 2020-07-14 | 2022-01-21 | 주식회사 코리아나화장품 | Cosmetic composition for improving skin condition comprising hemp seed oil, plant callus culture filtrate and peptides as active ingredient |
KR102214493B1 (en) * | 2020-07-29 | 2021-02-09 | 진성글로벌 주식회사 | Brass colouring method |
KR20220154918A (en) * | 2021-05-14 | 2022-11-22 | 씨앤알코스메틱스 주식회사 | Cosmetic composition containing Cudrania extract as an active ingredient |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6270811B1 (en) | Pharmaceutical, cosmetic composition with base of microbial culture mixed with an essential oil and an acid | |
KR101566820B1 (en) | Cosmetic composition containing moisturizing complex for moisturizing the skin | |
KR20080094457A (en) | Anti-wrinkle cosmetic composition | |
KR101456042B1 (en) | Anti-aging cosmetic composition | |
TW201206494A (en) | Use of Tiliacora triandra in cosmetics and compositions thereof | |
CN109662928A (en) | A kind of skin care compositions and its application and preparation method with sun-proof reparation effect | |
CN110384645A (en) | A kind of crease-resistant skin conditioning agent, U.S. restructuring compound for the neck and preparation method | |
KR101375137B1 (en) | A cosmetic composition comprising fermented extract of Scutellaria baicalensis using Leatiporus sulphureus var. miniatus for skin moisturizing | |
CN110393689A (en) | It is a kind of to have effects that anti-ageing essence composition and preparation method thereof | |
CN113368018A (en) | Anti-inflammatory acne-removing composition and preparation method thereof | |
CN112137904A (en) | Colorful water-light-skin-bottom essence and preparation method thereof | |
KR101292274B1 (en) | Cosmetic composition for anti-wrinkle | |
KR20080101419A (en) | Composition of skin external application containing green tea flower extract | |
KR20100006796A (en) | Anti-aging cosmetic composition comprising herb ferment extract | |
CN108553365A (en) | A kind of apple myofilament sliding surface film and preparation method thereof | |
CN111450031A (en) | Freeze-dried nanofiber invisible mask and preparation method thereof | |
CN114712285B (en) | Composition with anti-wrinkle effect and preparation method and application thereof | |
KR102657790B1 (en) | Cosmetic composition for improving skin elasticity containing natural extracts | |
KR102662972B1 (en) | Cosmetic composition for improving neck wrinkles and lip wrinkles | |
KR101435679B1 (en) | Composition for moisturizing and improving wrinkle on skin | |
KR101710005B1 (en) | Cosmetic composition comprising cheonjeongpalgindan as active ingredient | |
KR102108912B1 (en) | Composition for improving skin moisturizing and inflammation | |
KR101456064B1 (en) | Anti-wrinkle cosmetic composition | |
KR20150139679A (en) | Cosmetic compositions of Chinese herb medicines extract ferment for soybean fermented liquor | |
KR101002796B1 (en) | The cosmetic composition for the reduction of skin pores |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |